Englewood Lab, Inc. (KOSDAQ:950140)

Market Cap	240.40B +79.3%
Revenue (ttm)	204.62B +3.9%
Net Income	25.12B +68.4%
EPS	1,263.90 +68.4%
Shares Out	19.87M
PE Ratio	9.57
Forward PE	11.16
Dividend	100.00 (0.83%)
Ex-Dividend Date	Dec 29, 2025

Volume	138,957
Average Volume	146,698
Open	12,270
Previous Close	12,250
Day's Range	11,920 - 12,390
52-Week Range	6,950 - 16,910
Beta	0.47
RSI	45.97
Earnings Date	Feb 20, 2026

About Englewood Lab

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2004
• Country: United States
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950140

Financial Performance

In 2024, Englewood Lab's revenue was 182.22 billion, a decrease of -11.88% compared to the previous year's 206.78 billion. Earnings were 19.63 billion, a decrease of -5.37%.